Neutrogena COOLDRY SPORT Sunscreen Spray Recalled for cGMP Deviations
Johnson & Johnson is recalling Neutrogena COOLDRY SPORT sunscreen spray SPF 30 in two sizes nationwide due to cGMP (current Good Manufacturing Practice) deviations. The recall affects approximately 469,764 cans.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall initiated voluntarily for cGMP deviations (a manufacturing/quality control issue). The source text does not report any illnesses, injuries, or safety incidents; the hazard is manufacturing non-compliance. Per the rubric, voluntary precautionary recalls without reported harm and Class II recalls without hospitalization reports score at the Moderate level.
Plain-English summary
Johnson & Johnson Consumer, Inc. is recalling Neutrogena COOLDRY SPORT sunscreen spray SPF 30 in two sizes: 5.0 oz (141g) cans with UPC 0 86800 10035 5 and 8 oz (226g) cans with UPC 0 86800 10031 7. The product contains Avobenzone (3%), Homosalate (8%), Octisalate (5%), and Octocrylene (8%) as active ingredients.
The recall was initiated due to cGMP (current Good Manufacturing Practice) deviations identified by the manufacturer. Johnson & Johnson voluntarily initiated this recall. The FDA classified it as a Class II recall on September 24, 2021, with the recall initiation date of July 14, 2021.
The recalled product was distributed nationwide in the United States. Approximately 223,884 cans of the 5.0 oz size and 245,880 cans of the 8 oz size are affected. All affected lots are within their expiration dates.
Consumers should stop using the recalled product. Johnson & Johnson notified customers through email, fax, letter, press release, telephone, and direct visits.
The recalled product
- Product
- Neutrogena COOLDRY SPORT sunscreen spray SPF 30, Avobenzone (3%), Homosalate (8%), Octisalate (5%), Octocrylene (8%), a) Net Wt 5.0 oz (141g) (UPC 0 86800 10035 5) and b) Net Wt. 8 oz. (226 g) UPC 0 86800 10031 7 aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER INC., Skill
- Manufacturer
- Johnson & Johnson Consumer, Inc.
- Category
- Drug — Sunscreen / Topical
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 20 recalled by Johnson & Johnson Consumer, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Johnson & Johnson Consumer, Inc.
See all →- ModerateNeutrogena Beach Defense Sunscreen Spray Recalled for cGMP Deviations
FDA (Drugs) · 2021-10-06
- ModerateNeutrogena Ultra Sheer SPF 30 Body Mist Sunscreen Recall
FDA (Drugs) · 2021-10-06
- SevereNeutrogena Beach Defense Sunscreen Spray Recalled for Benzene Contamination
FDA (Drugs) · 2021-10-06
- ModerateNeutrogena Ultra Sheer Sunscreen Recalled for cGMP Deviations
FDA (Drugs) · 2021-10-06
- ModerateNeutrogena Beach Defense Sunscreen Spray Class II Drug Recall
FDA (Drugs) · 2021-10-06
Same hazard · cgmp deviation
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09